NOTCH2 and cancer: Combining WES data and TDS data, 75 specimens were evaluated (11 samples in WES and 64 samples in TDS); NOTCH2 mutations were determined in 20 samples (1 in the WES analysis and 19 in the TDS analysis) with a rate of 26.67 % (20 of 75) among cancer cases.